Arca Biopharma Stock Buy Hold or Sell Recommendation


USD 2.05  0.03  1.44%   

Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Arca Biopharma is 'Hold'. Macroaxis provides Arca Biopharma buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding ABIO positions. The advice algorithm takes into account all of Arca Biopharma's available fundamental, technical, and predictive indicators you will find on this site.
The advice is provided from Arca Biopharma's buy-and-hold perspective. Please continue to Arca Biopharma Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. We conduct extensive research on individual companies such as Arca Biopharma and provide practical buy, sell, or hold advice based on selected investing horizon and risk tolerance towards Arca Biopharma.

Execute Arca Biopharma Buy or Sell Advice

The Arca Biopharma recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Arca Biopharma. Macroaxis does not own or have any residual interests in Arca Biopharma or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Arca Biopharma's advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Arca BiopharmaBuy Arca Biopharma



Hype Condition


Current Valuation


Odds of Distress


Economic Sensitivity


Analyst Consensus


Reporting Quality (M-Score)

For the selected time horizon Arca Biopharma has a Risk Adjusted Performance of (0.11), Jensen Alpha of (0.19), Total Risk Alpha of (0.23) and Treynor Ratio of (0.56)
We provide trade advice to complement the prevailing expert consensus on Arca Biopharma. Our dynamic recommendation engine uses a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available at the time. To make sure Arca Biopharma is not overpriced, please confirm all Arca Biopharma fundamentals, including its shares owned by insiders, ebitda, cash flow from operations, as well as the relationship between the price to book and total debt . Please also double-check Arca Biopharma price to book to validate your buy or sell decision is consistent with all fundamental data available and that the company can sustain itself in the current economic cycle.

Arca Biopharma Trading Alerts and Improvement Suggestions

Arca Biopharma generated a negative expected return over the last 90 days
Arca Biopharma is unlikely to experience financial distress in the next 2 years
The company reported the previous year's revenue of 25.55 M. Net Loss for the year was (16.81 M) with profit before overhead, payroll, taxes, and interest of 28.37 M.
Arca Biopharma currently holds about 46.44 M in cash with (16.74 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.22, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Latest headline from One ARCA biopharma, Inc. insider upped their stake by 5,155 percent in the previous year - Yahoo Finance

Arca Biopharma Returns Distribution Density

The distribution of Arca Biopharma's historical returns is an attempt to chart the uncertainty of Arca Biopharma's future price movements. The chart of the probability distribution of Arca Biopharma stock daily returns describes the distribution of returns around its average expected value. We use Arca Biopharma price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Arca Biopharma returns is essential to provide solid investment advice for Arca Biopharma.
Mean Return-0.18Value At Risk-3.4
Potential Upside2.91Standard Deviation2.21
   Return Density   
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Arca Biopharma historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Arca Biopharma Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Arca Biopharma is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Arca Biopharma backward and forwards among themselves. Arca Biopharma's institutional investor refers to the entity that pools money to purchase Arca Biopharma's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Xtx Topco LtdCommon Shares10.8 K38 K
Wells Fargo CompanyCommon Shares96.00.0
Wells Fargo CompanyCommon Shares89.00.0
Wells Fargo CompanyCommon Shares88.00.0
Wells Fargo CompanyCommon Shares88.00.0
Wells Fargo CompanyCommon Shares1540.0
Wells Fargo CompanyCommon Shares60.00.0
Note, although Arca Biopharma's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Arca Biopharma Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Arca Biopharma or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Arca Biopharma's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Arca Biopharma stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
Alpha over DOW
Beta against DOW0.33
Overall volatility
Information ratio -0.1

Arca Biopharma Volatility Alert

Arca Biopharma exhibits very low volatility with skewness of 0.49 and kurtosis of 2.6. However, we advise investors to further study Arca Biopharma technical indicators to ensure that all market info is available and is reliable. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Arca Biopharma's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Arca Biopharma's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.

Arca Biopharma Fundamentals Vs Peers

Comparing Arca Biopharma's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Arca Biopharma's direct or indirect competition across all of the common fundamentals between Arca Biopharma and the related equities. This way, we can detect undervalued stocks with similar characteristics as Arca Biopharma or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Arca Biopharma's fundamental indicators could also be used in its relative valuation, which is a method of valuing Arca Biopharma by comparing valuation metrics with those of similar companies.
 Better Than Average     
 Worse Than Average Compare Arca Biopharma to competition
FundamentalsArca BiopharmaPeer Average
Return On Equity(31.66) %(0.31) %
Return On Asset(18.61) %(0.14) %
Current Valuation(15.88 M)16.62 B
Shares Outstanding14.41 M571.82 M
Shares Owned by Insiders0.74 %10.09 %
Shares Owned by Institutions34.44 %39.21 %
Number of Shares Shorted55.73 K4.71 M
Price to Earning(0.63) X28.72 X
Price to Book0.43 X9.51 X
Price to Sales2.08 X11.42 X
Revenue25.55 M9.43 B
Gross Profit28.37 M27.38 B
EBITDA(16.87 M)3.9 B
Net Income(16.81 M)570.98 M
Cash and Equivalents46.44 M2.7 B
Cash per Share3.22 X5.01 X
Total Debt435 K5.32 B
Debt to Equity0.009 %48.70 %
Current Ratio16.97 X2.16 X
Book Value Per Share4.87 X1.93 K
Cash Flow from Operations(16.74 M)971.22 M
Short Ratio1.72 X4.00 X
Earnings Per Share(2.07) X3.12 X
Number of Employees1718.84 K
Market Capitalization30.26 M19.03 B
Total Asset27.07 M29.47 B
Retained Earnings(155.82 M)9.33 B
Working Capital(20.73 M)1.48 B
Current Asset5.88 M9.34 B
Current Liabilities26.61 M7.9 B
Z Score34.48.72
   Arca Biopharma exotic insider transaction detected [view details]

Arca Biopharma Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Arca Biopharma . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Arca Biopharma Buy or Sell Advice

When is the right time to buy or sell Arca Biopharma? Buying financial instruments such as Arca Biopharma Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Arca Biopharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Top FinTech Thematic Idea Now

Top FinTech
Top FinTech Theme
High long term potential financial entities that are ranging from payment processing, investment management to commercial and investment banking. The Top FinTech theme has 75 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Top FinTech Theme or any other thematic opportunities.
View All  Next Launch
Please continue to Arca Biopharma Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Complementary Tools for analysis

When running Arca Biopharma price analysis, check to measure Arca Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arca Biopharma is operating at the current time. Most of Arca Biopharma's value examination focuses on studying past and present price action to predict the probability of Arca Biopharma's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Arca Biopharma's price. Additionally, you may evaluate how the addition of Arca Biopharma to your portfolios can decrease your overall portfolio volatility.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Is Arca Biopharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Arca Biopharma. If investors know Arca Biopharma will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Arca Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
29.5 M
Return On Assets
Return On Equity
The market value of Arca Biopharma is measured differently than its book value, which is the value of Arca Biopharma that is recorded on the company's balance sheet. Investors also form their own opinion of Arca Biopharma's value that differs from its market value or its book value, called intrinsic value, which is Arca Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Arca Biopharma's market value can be influenced by many factors that don't directly affect Arca Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Arca Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine Arca Biopharma value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Arca Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.